AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub


New technology and capacity help CDMO’s advanced-therapies campus meet growing market demand

SEATTLE, May 17, 2022, a leading global Biopharmaceutical Contract Development and Manufacturing Organizationin Longmont, Col., USA. These new…



Source link

Lascia un commento

Il tuo indirizzo email non sarà pubblicato.

 

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.